OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dupilumab: A Review of Present Indications and Off-Label Uses
Francisco J. Muñoz‐Bellido, Esther Moreno, Ignacio Dávila
Journal of Investigational Allergology and Clinical Immunology (2021) Vol. 32, Iss. 2, pp. 97-115
Open Access | Times Cited: 94

Showing 51-75 of 94 citing articles:

Il dupilumab nell’esofagite eosinofila: una nuova frontiera?
Martina Mainetti, Angela Troisi, Giuliana Turlà, et al.
Medico e Bambino (2022) Vol. 41, Iss. 1, pp. 583-587
Closed Access | Times Cited: 4

Simultaneous treatment of Samter triad and prurigo nodularis with dupilumab
Joshua Bloomstein, Jason E. Hawkes
JAAD Case Reports (2021) Vol. 18, pp. 20-22
Open Access | Times Cited: 4

Republication de : Dupilumab in pediatric severe chronic rhinosinusitis with nasal polyps and asthma
Mariana Bragança, Ana Margarida Pereira, José Luís Plácido, et al.
Annales françaises d Oto-rhino-laryngologie et de Pathologie Cervico-faciale (2024) Vol. 141, Iss. 1, pp. 53-54
Closed Access

A case of Dupilumab monotherapy in an IgG4-related disease patient
Yan Chen, Jiahui Zhao, Lingling Liu
JAAD Case Reports (2024)
Open Access

Bullous pemphigoid successfully treated with Dupilumab
Daniela de Abreu e Silva Martinez, Amanda de Freitas Sampaio Periquito, Giovanni Francisco Pérez Roa, et al.
Anais Brasileiros de Dermatologia (2024)
Open Access

Biological Therapy, Therapeutic Approaches and Future Perspectives in the Treatment of Chronic Rhinitis
Agata Magierska, Zuzanna Szczepaniak, Olga Ptak, et al.
Quality in Sport (2024) Vol. 18, pp. 52161-52161
Open Access

Dermatologische unerwünschte Arzneimittelwirkungen bei Behandlung mit Biologika – Pathogenese und Management
Laura Trefzer, Anna Caroline Pilz, Kilian Eyerich
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2024) Vol. 22, Iss. 8, pp. 1126-1137
Closed Access

Konventionelle und neue Behandlungsstrategien bei Porokeratosen: Eine narrative Übersicht
Yumeng La, Jie Zhu, Simon M. Mueller
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2024) Vol. 22, Iss. 8, pp. 1073-1078
Closed Access

Continued contribution to atopic innovation with dupilumab
Alex E Wright, W. C. Wood, Aakash Goyal
Current Opinion in Pediatrics (2024) Vol. 36, Iss. 5, pp. 537-541
Closed Access

The management of exercise-induced anaphylaxis in a Chinese child with biologics: a case report
Nannan Jiang, Xiang Li, Huijie Huang, et al.
Frontiers in Allergy (2024) Vol. 5
Open Access

Synthetic small interfering RNAs selectively suppress the expression of proinflammatory cytokine genes (IL-25 and TSLP) in experiments in vitro
M.M. Kaganova, I.P. Shilovskiy, E.D. Timotievich, et al.
Medical Immunology (Russia) (2024) Vol. 26, Iss. 5, pp. 1107-1114
Open Access

Dermatitis por contacto alérgica en el párpado: diagnóstico, diagnóstico diferencial y tratamiento
Edinson Lopez, Paloma Matus, Daniela Calderón, et al.
Piel (2024)
Closed Access

Dupilumab for Chronic Hand Eczema: A Systematic Review and Meta-Analysis
Hannah Riva, Teresa Yoon, Aleksi J. Hendricks, et al.
Dermatitis (2024)
Closed Access

Biologics in allergology and clinical immunology: Update on therapies for atopic diseases, urticaria, and angioedema and on safety aspects focusing on hypersensitivity reactions
Uta Jappe, Karl‐Christian Bergmann, Folke Brinkmann, et al.
Allergologie select (2024) Vol. 8, Iss. 01, pp. 365-406
Closed Access

Penfigoide bolhoso tratado com sucesso com dupilumabe
Daniela de Abreu e Silva Martinez, Amanda de Freitas Sampaio Periquito, Giovanni Francisco Pérez Roa, et al.
(2024) Vol. 99, Iss. 5, pp. 778-780
Open Access

Dupilumab for treatment of food-dependent, exercise-induced anaphylaxis
Liping Zhu, Rui Tang, Qīng Wáng, et al.
Authorea (Authorea) (2023)
Open Access | Times Cited: 1

Dupilumab zur Behandlung von Genodermatosen: Eine systematische Übersicht
Po‐Chien Wu, Ying‐Xiu Dai, Chia‐Lun Li, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2023) Vol. 21, Iss. 1, pp. 7-18
Closed Access | Times Cited: 1

Immunologic contact urticaria to milk in an adult patient with severe atopic dermatitis
Caterina Foti, Francesca Ambrogio, Eustachio Nettis, et al.
Contact Dermatitis (2023) Vol. 88, Iss. 6, pp. 495-496
Closed Access | Times Cited: 1

Dupilumab Therapy of Prurigo Nodularis: A Single-Center, Real-Life Observational Study
Wenwen Jing, Danyang Yang, Xin Liu, et al.
Dermatologic Therapy (2023) Vol. 2023, Iss. 1
Open Access | Times Cited: 1

Atopy in Chronic Urticaria: An Important yet Overlooked Issue
Qiquan Chen, Xianjie Yang, Bing Ni, et al.
Authorea (Authorea) (2023)
Open Access | Times Cited: 1

Reacción psoriasiforme por dupilumab
Laura Margarita Arango Bedoya, María Elizabeth Gaviria-Barrera
Piel (2024) Vol. 39, Iss. 5, pp. 266-269
Closed Access

Drug-Induced Erythema Annulare Centrifugum after Dupilumab Therapy: A Case Report.
Simran Kalsi, Santana VanDyke, Julia Barker, et al.
SKIN The Journal of Cutaneous Medicine (2024) Vol. 8, Iss. 2, pp. 1442-1445
Open Access

Scroll to top